We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRI icon
576
Capri Holdings
CPRI
$1.77B
$1.07M 0.02%
16,062
-3,128
-16% -$204K
DISCK
577
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1.06M 0.02%
41,562
-231
-0.6% -$5.15K
GGP
578
DELISTED
GGP Inc.
GGP
$1.06M 0.02%
51,876
+5,616
+12% +$114K
URI icon
579
United Rentals
URI
$71.1B
$1.04M 0.02%
7,082
-1,558
-18% -$255K
REG icon
580
Regency Centers
REG
$15B
$1.04M 0.02%
16,680
-467
-3% -$27.4K
ALV icon
581
Autoliv
ALV
$8.6B
$1.03M 0.02%
10,027
+47
+0.5% +$5.02K
SIVB
582
DELISTED
SVB Financial Group
SIVB
$1.03M 0.02%
3,571
-523
-13% -$154K
LULU icon
583
lululemon athletica
LULU
$13B
$1.02M 0.02%
8,174
-106,905
-93% -$11.4M
FLR icon
584
Fluor
FLR
$7.29B
$1.02M 0.02%
20,885
-12,446
-37% -$652K
WDAY icon
585
Workday
WDAY
$33.4B
$1.02M 0.02%
8,414
-892
-10% -$114K
SJM icon
586
J.M. Smucker
SJM
$12.6B
$1.02M 0.02%
9,468
MELI icon
587
Mercado Libre
MELI
$91.3B
$1.02M 0.02%
3,403
+460
+16% +$145K
TRU icon
588
TransUnion
TRU
$14.8B
$1M 0.02%
+14,032
New +$935K
NWL icon
589
Newell Brands
NWL
$2.16B
$995K 0.02%
38,577
+300
+0.8% +$7.81K
BG icon
590
Bunge Global
BG
$23.6B
$993K 0.02%
14,243
NOC icon
591
Northrop Grumman
NOC
$77B
$991K 0.02%
3,221
-122
-4% -$40.3K
NSTG
592
DELISTED
NanoString Technologies, Inc.
NSTG
$985K 0.02%
72,000
-8,000
-10% -$91.5K
IVZ icon
593
Invesco
IVZ
$13.3B
$982K 0.02%
36,958
-69
-0.2% -$1.99K
IFF icon
594
International Flavors & Fragrances
IFF
$19.4B
$980K 0.02%
7,903
-1,072
-12% -$140K
IFN
595
Aberdeen India Fund
IFN
$488M
$972K 0.02%
40,000
-8,000
-17% -$198K
BTI icon
596
British American Tobacco
BTI
$132B
$969K 0.02%
19,215
-12
-0.1% -$632
BX icon
597
Blackstone
BX
$104B
$965K 0.02%
+30,000
New +$955K
DBVT
598
DBV Technologies
DBVT
$807M
$965K 0.02%
5,000
TPR icon
599
Tapestry
TPR
$28.8B
$960K 0.02%
20,555
-18,232
-47% -$877K
VAR
600
DELISTED
Varian Medical Systems, Inc.
VAR
$958K 0.02%
8,428
-28,322
-77% -$3.39M

Similar funds

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.